Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors inside the central nervous procedure, conolidine modulates alternate molecular targets. A Science Innovations research identified that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid pept... https://ericy319kyn5.theideasblog.com/profile